NSE · Healthcare · Biotechnology
EPS came in at 11.56 against a street estimate of 16.91 — a miss of 31.6%.
| Document | Date |
|---|---|
| Quarterly results · Q1 FY27 HALEOS LABS LIMITED – Q1 FY2027 FINANCIAL SUMMARY HEADLINE NUMBERS Standalone Results (Quarter Ended June 30, 2026): • Revenue from Operations: Rs 6 | 2026-08-05 |
| Quarterly results · Q3 FY26 HALEOS LABS LIMITED – FINANCIAL SUMMARY Q3 FY2025-26 (Quarter & 9 Months Ended December 31, 2025) --- HEADLINE NUMBERS STANDALONE BASIS (Rs. in Lak | 2026-02-11 |
| Quarterly results · Q2 FY26 HALEOS LABS LIMITED – FINANCIAL SUMMARY (Formerly SMS Lifesciences India Limited) --- HEADLINE NUMBERS • Q2 FY2025-26 (Quarter ended 30 Sept 2025) | 2025-11-10 |
| Annual report FY2025 SMS LIFESCIENCES INDIA LIMITED — 2024-25 ANNUAL REPORT SUMMARY HEADLINE NUMBERS • Revenue from Operations: ₹34,472.35 lakhs (2024-25) vs ₹30,595.84 | 2025-09-06 |
| Quarterly results · Q1 FY26 SMS LIFESCIENCES INDIA LIMITED - Q1 FY2026 FINANCIAL SUMMARY HEADLINE NUMBERS • Standalone Revenue from Operations (Q1 FY2026): Rs 7,904.27 lakhs, d | 2025-08-11 |
| Quarterly results | 2025-02-12 |
| Quarterly results | 2024-11-13 |
| Annual report FY2024 SMS LIFESCIENCES INDIA LIMITED – ANNUAL REPORT 2023-24 SUMMARY HEADLINE NUMBERS • Revenue from Operations: ₹30,000.16 lakhs (FY 2023-24) vs ₹31,524. | 2024-09-06 |
Readable in the app.
| Action | Detail | Date |
|---|---|---|
| Dividend | ₹1.50 / share ex-date Sep 24, 2025 | 2025-09-24 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Haleos Labs Limited — free to start.
Google PlayApp StoreData updated 2026-09-18.